Microvasculature in diabetes

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 764-771

  Tooke, John E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Diabetes; Microcirculation

Indexed keywords

CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; HUMAN; MICROVASCULATURE; PRIORITY JOURNAL; REVIEW;

DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION;

EID: 0030271241     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00091-0     Document Type: Review

References (57)

1. [1] Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 1992;166:265-270.
2. [2] Malik RA, Tesfaye S, Thompson SD, Vcves A, Sharma AK, Boulton AJM, Ward JD. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 1993;36:454-459.
3. [3] Eurodiab IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the Eurodiab IDDM Complications Study. Diabetologia 1994;37:278-285.
4. [4] Eiser C, Tooke JE. Quality-of-lite evaluation in diabetes. PharmacoEconomics 1993;4:85-91.
5. [5] US Survey American Diabetes Association. Direct and indirect costs of diabetes in the United States in 1987. BDA, Washington, 1988.
6. [6] The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
7. [7] Bloodworth JM Jr. Fine structure of retina in human and canine diabetes mellitus. In: Kimura SJ, Caygill WM, eds. Vascular Complications of Diabetes Mellitus. St. Louis: CV Mosby, 1967:73-98.
8. [8] Osterby R, Gundersen HJG, Horlyck A, Kroustrup JP, Nyberg G, Westberg G. Diabetic glomerulopathy: structural characteristics of the early and advanced stages. Diabetes 1983;32(Suppl 2):79-82.
9. [9] Klein RF, Feingold KR, Morgan C, Stern WH, Siperstein MD. Relationship of muscle capillary basement membrane thickness and diabetic retinopathy. Diabetes Care 1987;10:195-199.
10. [10] Yasuda H, Taniguchi Y, Yamashita M, et al. Morphological characteristics of dermal diabetic microangiopathy. Diabetes Res Clin Pract (Amsterdam) 1990;9:187-194.
11. [11] Jaap AJ, Tooke JE. The pathophysiology of microvascular disease in non-insulin-dependent diabetes. Clin Sci 1995;89:3-12.
12. [12] Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-949.
13. [13] Tooke JE. Microvascular haemodynamics in diabetes mellitus. Clin Sci 1986;70:119-125.
14. [14] Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-415.
15. [15] Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992;327:760-764.
16. [16] Shore AC, Jaap AJ, Tooke JE. Capillary pressure in insulin dependent diabetic patients of long disease duration with and without microangiopathy. Diabetic Med 1992;9(Suppl. 2):S11(Abstract).
17. [17] Williams SA, Boolell M, MacGregor GA, Smaje LH, Wassermann S, Tooke JE. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci 1990;79:5-8.
18. [18] Shore AC, Sandeman DD, Tooke JE. Effect of an increase in systemic blood pressure on nailfold capillary pressure in humans. Am J Physiol 1993;265:H820-H823.
19. [19] Rayman G, Williams SA, Gamble J, Tooke JE. A study of the factors governing fluid filtration in the feet of diabetic and normal subjects. Eur J Clin Invest 1994;24:830-836.
20. [20] Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J 1986;292:1295-1298.
21. [21] Shore AC, Price KJ, Sandeman DD, Green EM, Tripp JH, Tooke JE. Impaired microvascular hyperaemic response in children with diabetes mellitus. Diabetic Med 1991;8:619-623.
22. [22] Kastrup J, Norgaard T, Parving H-H, Henriksen O, Lassen NA. Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction. Diabetologia 1985;28:711-717.
23. [23] Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989;32:219-226.
24. [24] Jaap AJ, Shore AC, Tooke JE. Capillary filtration coefficent is different in long duration type 1 diabetic patients with and without microvascular complications. Diabetic Med 1994;11(Suppl. 1):S13(Abstract).
25. [25] Shore AC, Jaap AJ, Tooke JE. Capillary pressure in patients with NIDDM. Diabetes 1994;43:1198-1202.
26. [26] Jaap AJ, Shore AC, Gamble J, Gartside IB, Tooke JE. Capillary filtration coefficient in type II (non-insulin-dependent) diabetes. J Diab Comp 1994;8:111-116.
27. [27] Sandeman DD, Pym CA, Green EM, Shore AC, Tooke JE. Profound impairment of microvascular vasodilation in the feet of newly diagnosed non-insulin-dependent diabetes (NIDDM). Diabetic Med 1990;7(Suppl. 2):7A(Abstract).
28. [28] Jaap AJ, Hammersley MS, Shore AC, Tooke JE. Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1994;37:214-216.
29. [29] Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance and β-cell dysfunction to reduced microvascular hyperaemia in subjects with impaired glucose tolerance. Diabetic Med 1995;44(Suppl 1):114A. Diabetes 1995;44(Suppl 1):114A.
30. [29] Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance and β-cell dysfunction to reduced microvascular hyperaemia in subjects with impaired glucose tolerance. Diabetic Med 1995;44(Suppl 1):114A. Diabetes 1995;44(Suppl 1):114A.
31. [30] Jaap AJ, Donohoe M, Shore AC, Tooke JE. Limited microvascular vasodilation in patients with acromegaly. J Endocrinol 1993;137(Suppl.):P45(Abstract).
32. [31] Johansson B-L, Kerrell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes Type 1. J Clin Endocrinol Metab 1993;77:976-981.
33. [32] Schneider DJ, Nordt TK, Sobel BE. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 1992;41:890-895.
34. [33] Lam KSL, Cheng IKP, Janus ED. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995;38:604-609.
35. [34] Kinoshita JH, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 1988;4:323-337.
36. [35] Brownlee M. Glycation and diabetic complications. Diabetes 1994;43:836-841.
37. [36] Poston L, Taylor PD. Endothelium mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 1995;in press:
38. [37] Elliott TG, Cockcroft JR, Groop P-H, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993;85:687-693.
39. [38] McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-776.
40. [39] Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995;in press.
41. [40] Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988;82:735-738.
42. [41] Williamson JR, Vogler NJ, Kilo C. Regional variations in the width of the basement membrane of muscle capillaries in man and giraffe. Am J Pathol 1971;63:359-367.
43. [42] Vracko R. Skeletal muscle capillaries in diabetics. Circulation 1970;41:271-283.
44. [43] Riser BL, Cortes P, Zhao X, et al. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1993;90:1932-1943.
45. [44] Raskin P, Pietri AO, Unger R, Shannon WA. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with type 1 diabetes mellitus. N Engl J Med 1983;309:1546-1550.
46. [45] Kohner EM, Henkind P. Correlation of fluoroscein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970;69:403-414.
47. [46] Colwell JA, Winocour PD, Halushka PV. Do platelets have anything to do with diabetic microvascular disease? Diabetes 1983;32(Suppl. 2):14-19.
48. [47] Schmid-Schonbein GW. The damaging potential of leukocyte activation in the microcirculation. Angiology 1993;44(1):45-56.
49. [48] Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991;139(1):81-100.
50. [49] Schmidt AM, Hori O, Chen JX, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 1995;96:1395-1403.
51. [50] Potter Van Loon BJ, Kluft C, Radder JK, Blankestein MA, Meinders AE. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 1993;42:945-9.
52. [51] Aiello LP, Avery RL, Arrigg PG, Keyt BA, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
53. [52] Sivalingham A, Kenney J, Brown CG, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-872.
54. [53] Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987;105:1455-1462.
55. [54] Tooke JE. Microvascular function in diabetes: a physiological perspective. Diabetes 1995;44:721-726.
56. [55] Shore AC, Donohoe M, Jaap AJ, Tooke JE. The effect of increasing doses of an angiotensin converting enzyme inhibitor on capillary pressure levels in patients with insulin-dependent-diabetes mellitus and microalbuminuria. Diabetic Med 1993;10(Suppl. 1):A18.55(Abstract).
57. [56] Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;1188:(Abstract).